Keyphrases
Interferon-α (IFN-α)
100%
Chronic Hepatitis B Virus Infection
100%
Lymphoblastoid
100%
Randomized Controlled Trial
100%
Europids
100%
Anti-HIV
60%
Confidence Interval
60%
Response Rate
60%
Hepatitis B Virus DNA
40%
Hepatitis B e Antigen (HBeAg)
40%
HIV-positive
40%
Response Predictors
20%
Hepatitis B Surface Antigen (HBsAg)
20%
Aspartate Aminotransferase
20%
Group by
20%
Pretreatment Variables
20%
Chronic Active Hepatitis
20%
Tertiary Care Hospital
20%
Addition Strategy
20%
HIV-negative Patients
20%
Thrice Weekly
20%
Effective Treatment
20%
Subcutaneous Injection
20%
Outpatient Clinic
20%
Nursing and Health Professions
Chronic Hepatitis B
100%
Alpha Interferon
100%
Alphan1 Interferon
100%
Confidence Interval
75%
Human Immunodeficiency Virus
75%
Virus DNA
50%
Hepatitis B(e) Antigen
50%
Hepatitis B
50%
Pilot Study
25%
Life Table
25%
Tertiary Care Center
25%
Hepatitis B Antigen
25%
Aspartate Aminotransferase Blood Level
25%
Chronic Active Hepatitis
25%
Outpatient Department
25%
Subcutaneous Injection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
100%
Chronic Hepatitis B
100%
Randomized Controlled Trial
100%
Alphan1 Interferon
100%
Anti-Human Immunodeficiency Virus
75%
Hepatitis B Virus
50%
Virus DNA
50%
Hepatitis B(e) Antigen
50%
Hepatitis B Antigen
25%
Aspartate Aminotransferase
25%
Subcutaneous Injection
25%
Life Table
25%
Chronic Active Hepatitis
25%